Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 352

1.

How Should We Treat Hospital-Acquired and Ventilator-Associated Pneumonia Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae?

Timsit JF, Pilmis B, Zahar JR.

Semin Respir Crit Care Med. 2017 Jun;38(3):287-300. doi: 10.1055/s-0037-1603112. Epub 2017 Jun 4. No abstract available.

PMID:
28578553
2.

Weekly high-dose liposomal amphotericin B (L-AmB) in critically ill septic patients with multiple Candida colonization: The AmBiDex study.

Azoulay E, Timsit JF, Lautrette A, Legriel S, Max A, Ruckly S, Misset B, Cohen Y, Wolff M.

PLoS One. 2017 May 22;12(5):e0177093. doi: 10.1371/journal.pone.0177093. eCollection 2017.

3.

Focus on severe infections.

Laupland KB, Paiva JA, Timsit JF.

Intensive Care Med. 2017 May 13. doi: 10.1007/s00134-017-4835-8. [Epub ahead of print] No abstract available.

PMID:
28501950
4.

The intensive care medicine research agenda on septic shock.

Perner A, Gordon AC, Angus DC, Lamontagne F, Machado F, Russell JA, Timsit JF, Marshall JC, Myburgh J, Shankar-Hari M, Singer M.

Intensive Care Med. 2017 May 12. doi: 10.1007/s00134-017-4821-1. [Epub ahead of print] Review.

PMID:
28500455
5.

Impact of respiratory viruses in hospital-acquired pneumonia in the intensive care unit: A single-center retrospective study.

Loubet P, Voiriot G, Houhou-Fidouh N, Neuville M, Bouadma L, Lescure FX, Descamps D, Timsit JF, Yazdanpanah Y, Visseaux B.

J Clin Virol. 2017 Jun;91:52-57. doi: 10.1016/j.jcv.2017.04.001. Epub 2017 Apr 22.

PMID:
28494435
6.

Potentially modifiable factors contributing to sepsis-associated encephalopathy.

Sonneville R, de Montmollin E, Poujade J, Garrouste-Orgeas M, Souweine B, Darmon M, Mariotte E, Argaud L, Barbier F, Goldgran-Toledano D, Marcotte G, Dumenil AS, Jamali S, Lacave G, Ruckly S, Mourvillier B, Timsit JF.

Intensive Care Med. 2017 May 2. doi: 10.1007/s00134-017-4807-z. [Epub ahead of print]

PMID:
28466149
7.

Appropriate endpoints for evaluation of new antibiotic therapies for severe infections: a perspective from COMBACTE's STAT-Net.

Timsit JF, de Kraker MEA, Sommer H, Weiss E, Bettiol E, Wolkewitz M, Nikolakopoulos S, Wilson D, Harbarth S; COMBACTE-NET consortium.

Intensive Care Med. 2017 May 2. doi: 10.1007/s00134-017-4802-4. [Epub ahead of print]

PMID:
28466147
8.

Bundle of care decreased ventilator-associated events-implications for ventilator-associated pneumonia prevention.

Neuville M, Mourvillier B, Bouadma L, Timsit JF.

J Thorac Dis. 2017 Mar;9(3):430-433. doi: 10.21037/jtd.2017.02.72. No abstract available.

9.

Bezlotoxumab and Recurrent Clostridium difficile Infection.

Sommer H, Timsit JF, Wolkewitz M; COMBACTE-NET Consortium.

N Engl J Med. 2017 Apr 20;376(16):1594. doi: 10.1056/NEJMc1702531. No abstract available.

PMID:
28423299
10.

"Salvage treatment" for infections by extensively- and pan-drug-resistant pathogens is common and often sub-optimal.

Poulakou G, Matthaiou DK, Bassetti M, Erdem H, Dimopoulos G, Curcio DJ, Carlet J, Lipman J, Timsit JF, Giamarellou H, Arfaras-Melainis A, Rello J; ESGCIP Investigators.

Intensive Care Med. 2017 Apr 13. doi: 10.1007/s00134-017-4796-y. [Epub ahead of print] No abstract available.

PMID:
28409204
11.

Performance and economic evaluation of the molecular detection of pathogens for patients with severe infections: the EVAMICA open-label, cluster-randomised, interventional crossover trial.

Cambau E, Durand-Zaleski I, Bretagne S, Brun-Buisson C, Cordonnier C, Duval X, Herwegh S, Pottecher J, Courcol R, Bastuji-Garin S; EVAMICA study team.

Intensive Care Med. 2017 Apr 3. doi: 10.1007/s00134-017-4766-4. [Epub ahead of print]

PMID:
28374097
12.

ICU-acquired candidaemia in France: Epidemiology and temporal trends, 2004-2013 - A study from the REA-RAISIN network.

Baldesi O, Bailly S, Ruckly S, Lepape A, L'Heriteau F, Aupee M, Boussat S, Bervas C, Machut A, Berger-Carbonne A, Savey A, Timsit JF; REA-RAISIN network.

J Infect. 2017 Jul;75(1):59-67. doi: 10.1016/j.jinf.2017.03.011. Epub 2017 Mar 31.

PMID:
28366686
13.

Systematic overdosing of oxa- and cloxacillin in severe infections treated in ICU: risk factors and side effects.

Neuville M, El-Helali N, Magalhaes E, Radjou A, Smonig R, Soubirou JF, Voiriot G, Le Monnier A, Ruckly S, Bouadma L, Sonneville R, Timsit JF, Mourvillier B.

Ann Intensive Care. 2017 Dec;7(1):34. doi: 10.1186/s13613-017-0255-8. Epub 2017 Mar 22.

14.

Persistent lymphopenia is a risk factor for ICU-acquired infections and for death in ICU patients with sustained hypotension at admission.

Adrie C, Lugosi M, Sonneville R, Souweine B, Ruckly S, Cartier JC, Garrouste-Orgeas M, Schwebel C, Timsit JF; OUTCOMEREA study group.

Ann Intensive Care. 2017 Dec;7(1):30. doi: 10.1186/s13613-017-0242-0. Epub 2017 Mar 17.

15.

Erratum to 'Predominance of healthcare-associated cases among episodes of community-onset bacteraemia due to extended-spectrum β-lactamase-producing Enterobacteriaceae' [International Journal of Antimicrobial Agents 49/1 67-73].

Zahar JR, Lesprit P, Ruckly S, Eden A, Hikombo H, Bernard L, Harbarth S, Timsit JF, Brun-Buisson C; BacterCom Study Group.

Int J Antimicrob Agents. 2017 Apr;49(4):480-481. doi: 10.1016/j.ijantimicag.2017.02.007. Epub 2017 Mar 6. No abstract available.

PMID:
28279672
16.

Evaluation of eight biomarkers to predict short term mortality in patients with acute severe dyspnea.

Ara-Somohano C, Bonadona A, Carpentier F, Pavese P, Vesin A, Hamidfar-Roy R, Minet C, Vanzetto G, Schwebel C, Timsit JF.

Minerva Anestesiol. 2017 Mar 8. doi: 10.23736/S0375-9393.17.10882-5. [Epub ahead of print]

PMID:
28275223
17.

Intensive care medicine research agenda on invasive fungal infection in critically ill patients.

Bassetti M, Garnacho-Montero J, Calandra T, Kullberg B, Dimopoulos G, Azoulay E, Chakrabarti A, Kett D, Leon C, Ostrosky-Zeichner L, Sanguinetti M, Timsit JF, Richardson MD, Shorr A, Cornely OA.

Intensive Care Med. 2017 Mar 2. doi: 10.1007/s00134-017-4731-2. [Epub ahead of print] Review.

PMID:
28255613
18.

Impact of echinocandin on prognosis of proven invasive candidiasis in ICU: A post-hoc causal inference model using the AmarCAND2 study.

Bailly S, Leroy O, Azoulay E, Montravers P, Constantin JM, Dupont H, Guillemot D, Lortholary O, Mira JP, Perrigault PF, Gangneux JP, Timsit JF; AmarCAND2 Study Group.

J Infect. 2017 Apr;74(4):408-417. doi: 10.1016/j.jinf.2016.12.016. Epub 2017 Jan 16.

PMID:
28104387
19.

Impact of transfusion on patients with sepsis admitted in intensive care unit: a systematic review and meta-analysis.

Dupuis C, Sonneville R, Adrie C, Gros A, Darmon M, Bouadma L, Timsit JF.

Ann Intensive Care. 2017 Dec;7(1):5. doi: 10.1186/s13613-016-0226-5. Epub 2017 Jan 4. Review.

20.

Delayed management of Staphyloccocus aureus infective endocarditis in a Middle East respiratory syndrome coronavirus possible case hospitalized in 2015 in Paris, France.

Bleibtreu A, Arias P, Vallois D, Debit A, Lermuzeaux M, Rioux C, Cabras O, Lucet JC, Choquet C, Timsit JF, Yazdanpanah Y, Lescure FX.

Clin Microbiol Infect. 2017 Jun;23(6):416-417. doi: 10.1016/j.cmi.2016.11.021. Epub 2016 Dec 13. No abstract available.

PMID:
27986520

Supplemental Content

Loading ...
Support Center